LON:PRTC PureTech Health (PRTC) Share Price, News & Analysis GBX 134.80 -2.20 (-1.61%) As of 11:54 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock About PureTech Health Stock (LON:PRTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PureTech Health alerts:Sign Up Key Stats Today's Range 133.20▼ 136.6050-Day Range 106.40▼ 144.8052-Week Range 100.40▼ 178Volume259,057 shsAverage Volume771,118 shsMarket Capitalization£325.79 millionP/E Ratio792.94Dividend YieldN/APrice TargetGBX 455Consensus RatingBuy Company Overview PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts. Read More PureTech Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks36th Percentile Overall ScorePRTC MarketRank™: PureTech Health scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingPureTech Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Upside PotentialPureTech Health has a consensus price target of GBX 455, representing about 237.5% upside from its current price of GBX 134.80.Amount of Analyst CoveragePureTech Health has received no research coverage in the past 90 days.Read more about PureTech Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of PureTech Health is 792.94, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 234.05.Price to Earnings Ratio vs. SectorThe P/E ratio of PureTech Health is 792.94, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 85.68.Price to Book Value per Share RatioPureTech Health has a P/B Ratio of 1.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for PRTC. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPureTech Health does not currently pay a dividend.Dividend GrowthPureTech Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for PRTC. News and Social Media0.6 / 5News SentimentN/A Search Interest4 people have searched for PRTC on MarketBeat in the last 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, PureTech Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought £191,333.75 in company stock and sold GBX 0 in company stock.Percentage Held by Insiders13.44% of the stock of PureTech Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions53.06% of the stock of PureTech Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PureTech Health's insider trading history. Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRTC Stock News HeadlinesPureTech Health (LON:PRTC) Insider Buys £36,548.75 in StockSeptember 25, 2025 | insidertrades.comPureTech Presents New Data from Phase 2b Open-Label Extension Study of Deupirfenidone (LYT-100), Further Supporting Strong and Durable Efficacy and Potential to Serve as New ...September 29, 2025 | finance.yahoo.comURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash before 2025 ends.October 8 at 2:00 AM | StockEarnings (Ad)PureTech Health says Seaport Therapeutics doses first patient in GlyphAgo studySeptember 11, 2025 | msn.comPureTech Health Advances Deupirfenidone in IPF TreatmentAugust 21, 2025 | msn.comPureTech Showcases Differentiated Development Strategy, Including New Patient Preference Insights, and Spotlights Phase 2b Data Positioning Deupirfenidone as a Potential New ...August 21, 2025 | sg.finance.yahoo.comPureTech Health to Announce Half-Yearly Financial ResultsAugust 18, 2025 | msn.comPureTech says Vedanta ulcerative colitis study missed endpointAugust 14, 2025 | msn.comSee More Headlines PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed this year? PureTech Health's stock was trading at GBX 150.20 on January 1st, 2025. Since then, PRTC shares have decreased by 10.3% and is now trading at GBX 134.80. How do I buy shares of PureTech Health? Shares of PRTC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of PureTech Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that PureTech Health investors own include IQE (IQE), Royal Dutch Shell (RDSB), BP (BP), GSK (GSK), Hummingbird Resources (HUM), Plug Power (PLUG) and AstraZeneca (AZN). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PRTC CIKN/A Webpuretechhealth.com Phone+1-617-4822333FaxN/AEmployees300Year FoundedN/APrice Target and Rating Average Price Target for PureTech HealthGBX 455 High Price TargetGBX 455 Low Price TargetGBX 455 Potential Upside/Downside+237.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX 0.17 Trailing P/E Ratio792.94 Forward P/E RatioN/A P/E GrowthN/ANet Income-£91.86 million Net Margins-17,620.94% Pretax MarginN/A Return on Equity-21.15% Return on Assets-13.39% Debt Debt-to-Equity Ratio45.82 Current Ratio3.68 Quick Ratio2.51 Sales & Book Value Annual Sales£6.17 million Price / Sales52.84 Cash FlowGBX 62.94 per share Price / Cash Flow2.14 Book ValueGBX 113.55 per share Price / Book1.19Miscellaneous Outstanding Shares241,684,000Free FloatN/AMarket Cap£325.79 million OptionableNot Optionable Beta1.02 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (LON:PRTC) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.